Gazelle® Diagnostic Platform, Designed for Low Resource Settings, Integrates Miniaturized Technologies with AI to Transform Disease Screening and Diagnosis
17 juin 2020 03h01 HE
|
Hemex Health
8-minute, Low-Cost Diagnostic Test for Sickle Cell Disease (SCD) Among First Approved Tests Includes a One-Minute Malaria Test with Solutions for Other Health Priorities to Follow PORTLAND, Ore. and...
PAI Life Science’s Biochemistry Expertise Links with Hemex Health’s Gazelle™ Miniaturized Rapid Diagnostic Platform to Develop Pandemic Test
15 avr. 2020 11h00 HE
|
Hemex Health
SEATTLE and PORTLAND, Ore., April 15, 2020 (GLOBE NEWSWIRE) -- Researchers in Seattle and Portland have agreed to collaborate on an urgently needed rapid COVID-19 diagnostic test that can diagnose...
Global Hydroxychloroquine Market Is Expected to Reach 5,549.65 Million by 2027 : Fior Markets
10 avr. 2020 05h12 HE
|
Fior Markets
Newark, NJ, April 10, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global hydroxychloroquine market is expected to grow from USD 542.36 million in 2019 and to reach USD...
Co-Diagnostics, Inc. Continues to Execute on International Expansion
29 oct. 2019 06h30 HE
|
Co-Diagnostics
Salt Lake City, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Salt Lake City, Utah – October 29, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique,...
UVA School of Data Science Leverages Machine Learning to Solve Global Challenges
22 oct. 2019 10h46 HE
|
University of Virginia School of Data Science
Charlottesville, Va., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Climate change, global health, and cyber security are just a few of the challenges that researchers at the University of Virginia School of...
GeoVax Announces Reverse Stock Split
03 mai 2019 08h59 HE
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
GeoVax Provides Product Development and Corporate Update
11 mars 2019 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...
HitGen Launching Initiative to Discover New Medicines to Combat Tuberculosis and Malaria
02 août 2018 20h00 HE
|
HitGen Ltd.
CHENGDU, China, Aug. 03, 2018 (GLOBE NEWSWIRE) -- HitGen Ltd., a privately held biotech company, announced today a three-year grant from the Bill & Melinda Gates Foundation. The grant will be...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7
22 mai 2018 09h00 HE
|
GeoVax, Inc.
CEO Robert McNally to Speak as part of BIO’s One Health Day Program ATLANTA, GA., May 22, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...
Manus Bio Awarded Funding to Develop Novel Production Method for Artemisinin
11 janv. 2018 10h51 HE
|
Manus Bio
CAMBRIDGE, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...